ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fremes, S. E.
Right arrow Articles by Mickle, D. A. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fremes, S. E.
Right arrow Articles by Mickle, D. A. G.

Ann Thorac Surg 1995;59:1127-1133
© 1995 The Society of Thoracic Surgeons

Cardiac Storage With University of Wisconsin Solution and a Nucleoside-Transport Blocker

Stephen E. Fremes, MD, Robert D. Furukawa, BSc, Ji Zhang, MD, Ren-Ke Li, MD, PhD, Laura C. Tumiati, BSc, Richard D. Weisel, MD, Donald A. G. Mickle, MD

Divisions of Cardiovascular Surgery and Clinical Biochemistry, Centre for Cardiovascular Research, University of Toronto, Toronto, Ontario, Canada

Accepted for publication January 19, 1995.

Findings from previous investigations conducted at this institution and others have suggested that University of Wisconsin solution (UWS) is preferable for the prolonged hypothermic storage of hearts before transplantation. The benefit seen with UWS may in part be related to the inclusion of adenosine (5 mmol/L) in the UWS. To investigate whether further manipulations of adenosine metabolism might enhance myocardial protection, studies were initially conducted using cultured myocytes, followed by confirmatory experiments using isolated rat hearts. Cultured human ventricular myocytes (7 to 8 dishes/group) were stored for 12 hours at 0°C in unmodified UWS or UWS supplemented with increasing concentrations (1 to 100 µmol/L) of the nucleoside-transport blocker p-nitrobenzylthioinosine. The adenosine triphosphate concentrations were found to be enhanced with nucleoside-transport inhibition, with the best results achieved with the 1- and 3-µmol/L groups (control, 3.37 ± 0.41 nmol/µg DNA; UWS, 2.89 ± 1.31 nmol/µg DNA; 1 µmol/L, 5.91 ± 3.23 nmol/µg DNA; 3 µmol/L, 7.86 ± 3.45 nmol/µg DNA; p < 0.05 versus control or UWS group). Isolated rodent hearts from Sprague-Dawley rats were prepared on a Langendorff apparatus with an intraventricular balloon and subsequently stored for 8 hours at 0°C in unmodified UWS (13 hearts/group) or UWS supplemented with 1 or 3 µmol/L of p-nitrobenzylthioinosine (9 to 10 hearts/group). In separate experiments (5 to 6 hearts/group), the tissue levels of purine metabolites were monitored. The addition of the nucleoside-transport blocker was associated with an increased postischemic developed pressure (UWS, 66.2% ± 11.1%; 1 µmol/L, 75.8% ± 6.4%; 3 µmol/L, 78.3% ± 10.7%; p < 0.05 UWS versus 1- or 3-µmol/L group) while diastolic compliance was reduced after storage in all groups (p = 0.01). Coronary flow was increased in association with the nucleoside-transport blocker (UWS, 71.3% ± 16.7%; 1 µmol/L, 78.5% ± 11.0%; 3 µmol/L, 86.6% ± 13.3%; p < 0.05 UWS versus 3 µmol/L). The p-nitrobenzylthioinosine did seem to block nucleoside transport, as the hypoxanthine content was unmeasurable after perfusion in the treated groups compared with the findings in the group receiving unmodified UWS (p < 0.01).




This article has been cited by other articles:


Home page
CirculationHome page
K. Matsubayashi, P. W.M. Fedak, D. A.G. Mickle, R. D. Weisel, T. Ozawa, and R.-K. Li
Improved Left Ventricular Aneurysm Repair With Bioengineered Vascular Smooth Muscle Grafts
Circulation, September 9, 2003; 108(90101): II-219 - 225.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
R.-K. Li, D. A.G. Mickle, R. D. Weisel, V. Rao, and Z.-Q. Jia
Optimal time for cardiomyocyte transplantation to maximize myocardial function after left ventricular injury
Ann. Thorac. Surg., December 1, 2001; 72(6): 1957 - 1963.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
T. Sakai, R.-K. Li, R. D. Weisel, D. A.G. Mickle, E.-J. Kim, S. Tomita, Z.-Q. Jia, and T. M. Yau
Autologous heart cell transplantation improves cardiac function after myocardial injury
Ann. Thorac. Surg., December 1, 1999; 68(6): 2074 - 2080.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
T. Sakai, R.-K. Li, R. D. Weisel, D. A.G. Mickle, Z.-Q. Jia, S. Tomita, E.-J. Kim, and T. M. Yau
FETAL CELL TRANSPLANTATION: A COMPARISON OF THREE CELL TYPES
J. Thorac. Cardiovasc. Surg., October 1, 1999; 118(4): 715 - 725.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. Zhang, R. D. Furukawa, S. E. Fremes, D. A. G. Mickle, and R. D. Weisel
Effects of Butanedione Monoxime and Temperature on Prolonged Cardiac Storage
Ann. Thorac. Surg., February 1, 1997; 63(2): 388 - 394.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1995 by The Society of Thoracic Surgeons.